For Immediate Release:
medicine society recognizes
CHICAGO, May 15, 2002The American College of Occupational and Environmental Health (ACOEM) has selected Bristol-Myers Squibb, New York, N.Y., as a recipient of the 2002 Corporate Health Achievement Award (CHAA). The company was selected based on its exemplary policies and guidelines for employees relating to reproductive health and cytotoxic drug handling. Additionally, Bristol-Myers Squibb has an exceptional medical surveillance program for early detection of potential occupational related health effects.
The Award was presented April 17 during ACOEMs annual American Occupational Health Conference in Chicago, Ill. Colin Baigel, MD, Corporate Medical Director, accepted the Award on behalf of Bristol-Myers Squibb.
ACOEM, an international medical specialty society of more than 6,000 occupational and environmental medicine physicians, recognizes the best corporate health programs in America through the CHAA competition. The Award honors and provides national recognition to North American corporations and institutions exhibiting excellence in employee health, safety and environmental management, and recognizes the finest health programs in America. Competing organizations are judged on their commitment to, and excellence in, creating comprehensive and innovative health and safety programs. Examiners look for measurable results in 23 quality categories covering four areas healthy people, a healthy environment, a healthy company, and management and leadership.
Bristol-Myers Squibb has an impressive breadth of programs focusing on maintaining and enhancing the health of its employees. The review committee was particularly impressed with the companys proactive approach in implementing medical surveillance programs for cytotoxic drug handlers, its establishment of exposure guidelines for new compound development, and its commitment to the community in which it operates. For example, in New Brunswick, New Jersey, Bristol-Myers Squibb has outfitted the local emergency medical systems with automatic external defibrillators (AEDs) similar to those the company utilizes in its facilities. This interaction demonstrates Bristol-Myers Squibbs commitment to preserving and enhancing the communities in which they are located.
# # #
| CHAA Home | ACOEM Home | GlaxoSmithKline |